Cytocraft Biopharmaceutical Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Cytocraft Biopharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| SDTM001 Injection as Adjuvant Therapy for NSCLC Patients After Radical Surgical Resection (NCT07096882) | Cytocraft Biopharmaceutical Co., Ltd. | 2025-07-26 |
Track Cytocraft Biopharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.